Latest Articles
Stellate ganglion block as a treatment for vasomotor symptoms: Clinical applicationHormone therapy is the mainstay of treatment, but there is a clear need for safe and effective nonhormonal options. The authors review data on the use of stellate ganglion block in perimenopausal and postmenopausal patients.
- Vitamin D supplementation: Pearls for practicing clinicians
A review of how to assess and counsel patients on the use of vitamin D, with patient scenarios clinicians are likely to encounter, and an overview of current recommendations for vitamin D supplementation.
- Potential systemic benefits of shocking or blocking nerves
What has really caught my attention is the expanding research on controlled regional neuromodulation and its impact on systemic physiology and inflammation.
- Hypercalcemia and vitamin A: A vitamin to keep in mind
Vitamin A toxicity can affect bone resorption and hypercalcemia and should be explored in unexplained cases of parathyroid hormone-independent hypercalcemia.
- Anaphylaxis: Expanding our perspective
Anaphylaxis is not always the extreme scenario we learned about in medical school. There is a range of far milder allergic infusion reactions that are nonetheless anaphylaxis.
- Anaphylaxis: Highlights from the practice parameter update
The update addresses diagnostic criteria, treatment options, prevention of recurrences, and patient education on avoiding triggers and using self-injectable epinephrine.
- Hypertrichosis and topical corticosteroid use
The xerotic dermatitis had resolved 2 years earlier, but the patient had continued to apply the medication.
- Extraosseous calcification in kidney disease
A review of the pathogenesis, presentation, diagnosis, and treatment of vascular and soft tissue calcifi cation.
- Discontinuing antidepressants: Pearls and pitfalls
To date, no formal schedule for tapering antidepressants has been validated. The maxim “slower is better” applies.
- Clinical impact of 2020 American Heart Association statement on menopause and cardiovascular disease risk
The statement supports the notion that the transition of menopause itself leads to increased cardiovascular risk and mortality.
